Company Overview and News

 
Two Japanese Investors Take Stake In GA Telesis

2018-10-02 aviationweek
Tokyo Century Corp. and an ANA Holdings subsidiary plan to take a majority stake in GA Telesis, the aftermarket services and engine leasing company. The stakeholder change is prompted by Global Principal Finance Co., a wholly owned subsidiary of Bank of America and investor in GA Telesis since 2007, which wanted to “harvest their investment” in a healthy market, says Abdol Moabery, GA Telesis’ president and CEO.
8439 ALNPY ALNPF 9202

15
Faulty Rolls-Royce engines have grounded some Boeing 787 jets

2018-09-29 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
GEC GE AIR ANZFY AIZ NWARF ANZLY BOE ALNPY ANZFF GNE ALNPF BA 9202

1
Japanese firms prepare for large-scale volunteering during 2020 Games

2018-09-27 japantimes.co.jp
Major companies are encouraging employees to volunteer for the 2020 Tokyo Olympics and Paralympics, after the Tokyo Organizing Committee started their search for 80,000 on Wednesday.
MZHOF NMR TM TYT TOYOF 8604 N33 NRSCF ALNPY 7203 ALNPF 8411 9202 MFG

1
First ANA A380 Takes to the Skies

2018-09-18 asdnews - 1
The first A380 for All Nippon Airways (ANA) took to the skies today, completing a maiden flight from the Final Assembly Line (FAL) in Toulouse, France to the Airbus site in Hamburg, Germany. The aircraft is now being prepared for cabin installation and painting in the airline’s special A380 livery.
ALNPY ALNPF 9202

 
Rescuers with dogs search for survivors after deadly Japan quake

2018-09-07 channelnewsasia
Rescue workers with dogs searched for survivors on Friday in debris-strewn landslides caused by an earthquake in Japan's northern island of Hokkaido that killed at least 16 people, officials said, with 26 still missing.
JAPSY TOPPY TM ALNPY 7203 TONPF TYT ALNPF 9202 TOYOF

 
Nikkei down as typhoon damage fears hit cosmetics shares

2018-09-05 reuters
TOKYO, Sept 5 (Reuters) - Japanese shares fell on Wednesday as worries that a tariff war between China and the United States could escalate weighed on sentiment, while concerns that tourists will shop less due to a typhoon flooding a major airport hit shares in cosmetic makers.
JAPSY PORBF ALNPY ALNPF 9202 4927 LN

 
Typhoon damage fears, trade disputes, hit Japanese shares

2018-09-05 reuters
TOKYO, Sept 5 (Reuters) - Concerns about economic damage from a powerful typhoon as well as underlying caution over international trade disputes hit Japanese shares on Wednesday, putting the Nikkei index on course for a fourth consecutive day of losses.
JAPSY PORBF ALNPY ALNPF 9202 4927 LN

 
Typhoon Jebi makes landfall in Japan, strongest in 25 years

2018-09-04 bworldonline
Typhoon Jebi made landfall in western Japan on Tuesday, the strongest tropical cyclone to come ashore in 25 years, and has picked up speed as it bears down on one of the nation’s most densely populated areas.
9021 PCRFY JAPSY TM TYT MRAAY TOYOF KYO MRAAF ALNPY 7203 ALNPF 9202

 
Typhoon Jebi makes landfall in Japan, strongest in 25 years

2018-09-04 theedgemarkets
(Sept 4): Typhoon Jebi made landfall in western Japan on Tuesday, the strongest tropical cyclone to come ashore in Japan in 25 years, and has picked up speed as it bears down on one of Japan’s most densely populated areas.
9021 PCRFY JAPSY TM TYT MRAAY TOYOF KYO MRAAF ALNPY 7203 ALNPF 9202

 
Japanese startup PD AeroSpace aims for commercial space travel in 2023

2018-09-04 japantimes.co.jp
NAGOYA – The startup PD AeroSpace Ltd. is developing a reusable spacecraft shaped like an airplane to carry paying customers into space by 2023.
ALNPY ALNPF 9202

 
First ANA A380 Rolls Out of Final Assembly Line in Toulouse

2018-08-31 asdnews
The first A380 for All Nippon Airways (ANA) has rolled out of the final assembly line (FAL) in Toulouse. The aircraft has now been moved to an outside station where various ground tests will be undertaken in preparation for first flight in the coming weeks. The aircraft will then be transferred to the Airbus facilities in Hamburg for cabin installation and painting.
ALNPY ALNPF 9202

 
Uber enlists Japan among 5 candidate countries to test flying taxis

2018-08-30 japantimes.co.jp
Uber Technologies Inc. said Thursday it will choose a city from five countries including Japan to test its flying taxi services, aiming to launch commercial operations in 2023.
ALNPY ALNPF 9202

1
Japan to See Flying Cars in a Decade: 3 Stocks to Watch

2018-08-28 zacks
Three-dimensional transportation networks could be a reality with flying cars hovering over Tokyo in a decade, as the world’s biggest innovation giants team up with the Japanese government to develop the technology.
ECR JAPSY AIR TM GELYF TYT LMHA GELYY DDAIF TOYOF LMHB 0175 VLKAF BOE ALNPY 7203 ALNPF BA 9202 VLKAY LM

203
Stocks To Watch: Tesla Twist And Retail Rally

2018-08-25 seekingalpha - 2
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
ROP JAPSY TYEKF GES AOBC TWX ANF AMBA CRM WMT RGR DLTR JWN DSW AMZN SCVL CATO AEO DKS BOX ALNPF NWY HSY AMC TMUS HAIN BBY AKCA MHH CZR JT IONS ALNPY FLL GRVY MSFT LVS BA GCO MGM WSM TIF VAC TM ULTA IBKR NFLX RRR VMW ATVI PPDF GDEN LULU HEI AMTD HZNP SONO EA COTV WYNN CWK XNET COST M DEST VSTO TGT S SCHW JPM DL ETFC DG TSLA ARLO URBN 9202 FIVE ILG BYD

 
The sky is the limit? Japan to form public-private panel on flying cars

2018-08-25 japantimes.co.jp
The industry ministry has said that it will set up a public-private panel to discuss ways to turn the concept of flying cars capable of carrying multiple people into reality.
BOE ALNPY ALNPF 9202 BA

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

CUSIP: 032350100